Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

por Church, Alison, Beerahee, Misba, Brooks, Jean, Mehta, Rashmi, Shah, Palvi
Publicado 2014

Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

por Singh, Dave, Worsley, Sally, Zhu, Chang-Qing, Hardaker, Liz, Church, Alison
Publicado 2015

Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study

por Zheng, Jinping, Zhong, Nanshan, Newlands, Amy, Church, Alison, Goh, Aik H
Publicado 2015

Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies

por Siler, Thomas M., Kerwin, Edward, Singletary, Karen, Brooks, Jean, Church, Alison
Publicado 2016

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, ra...

por Donohue, James F, Niewoehner, Dennis, Brooks, Jean, O’Dell, Dianne, Church, Alison
Publicado 2014

A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD

por Rheault, Tara, Khindri, Sanjeev, Vahdati-Bolouri, Mitra, Church, Alison, Fahy, William A.
Publicado 2016

Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials

por Riley, John H, Tabberer, Maggie, Richard, Nathalie, Donald, Alison, Church, Alison, Harris, Stephanie S
Publicado 2016

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD

por Siler, Thomas M, Donald, Alison C, O’Dell, Dianne, Church, Alison, Fahy, William A
Publicado 2016

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD

por Feldman, Gregory, Maltais, François, Khindri, Sanjeev, Vahdati-Bolouri, Mitra, Church, Alison, Fahy, William A, Trivedi, Roopa
Publicado 2016

The effect of umeclidinium added to inhaled corticosteroid/long-acting β(2)-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study

por Sousa, Ana R, Riley, John H, Church, Alison, Zhu, Chang-Qing, Punekar, Yogesh S, Fahy, William A
Publicado 2016

Mast cell desensitization inhibits calcium flux and aberrantly remodels actin

por Ang, W.X. Gladys, Church, Alison M., Kulis, Mike, Choi, Hae Woong, Burks, A. Wesley, Abraham, Soman N.
Publicado 2016

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

por Kerwin, Edward M, Kalberg, Chris J, Galkin, Dmitry V, Zhu, Chang-Qing, Church, Alison, Riley, John H, Fahy, William A
Publicado 2017